JPH0563156B2 - - Google Patents
Info
- Publication number
- JPH0563156B2 JPH0563156B2 JP13893988A JP13893988A JPH0563156B2 JP H0563156 B2 JPH0563156 B2 JP H0563156B2 JP 13893988 A JP13893988 A JP 13893988A JP 13893988 A JP13893988 A JP 13893988A JP H0563156 B2 JPH0563156 B2 JP H0563156B2
- Authority
- JP
- Japan
- Prior art keywords
- alanine
- medium
- brevibacterium
- accumulated
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 66
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 47
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 27
- 229960003767 alanine Drugs 0.000 claims description 27
- 241000186146 Brevibacterium Species 0.000 claims description 13
- 244000005700 microbiome Species 0.000 claims description 13
- 235000004279 alanine Nutrition 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000002609 medium Substances 0.000 description 13
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 13
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 229950010030 dl-alanine Drugs 0.000 description 7
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 6
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 6
- 235000020958 biotin Nutrition 0.000 description 6
- 239000011616 biotin Substances 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 229910000160 potassium phosphate Inorganic materials 0.000 description 6
- 235000011009 potassium phosphates Nutrition 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 3
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- QLULGSLAHXLKSR-UHFFFAOYSA-N azane;phosphane Chemical compound N.P QLULGSLAHXLKSR-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229960003077 cycloserine Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- -1 glucose Chemical class 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000012607 strong cation exchange resin Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】
<産業上の利用分野>
本発明は、工業的に有利なD−アラニンの製造
法に関する。DETAILED DESCRIPTION OF THE INVENTION <Industrial Field of Application> The present invention relates to an industrially advantageous method for producing D-alanine.
D−アラニンは、非天然型アミノ酸であるが、
それ自体試薬としてあるいはペプチドなどの合成
原料として有用な化合物であり近年その需要も増
加している。 D-alanine is a non-natural amino acid,
It is a compound itself useful as a reagent or as a raw material for the synthesis of peptides and the like, and demand for it has increased in recent years.
<従来の技術>
従来より、ブレビバクテリウム属に属する微生
物により発酵法によつてDL−アラニンを製造す
る方法は数多く知られている〔アミノ酸発酵(下
巻)第119頁、共立出版(昭和47年出版)〕。<Prior art> Many methods have been known to produce DL-alanine by fermentation using microorganisms belonging to the genus Brevibacterium [Amino Acid Fermentation (Vol. 2), p. 119, Kyoritsu Shuppan (1971). Publication)].
また、DL−アラニンを原料とし、L−アラニ
ンを酵母に資化させることによるD−アラニンを
調製する方法も知られている(Amino Acid・
Nuclic Acid,1967、第15号、89−94)。 Additionally, a method for preparing D-alanine by using DL-alanine as a raw material and assimilating L-alanine into yeast is also known (Amino Acid.
Nuclic Acid, 1967, No. 15, 89-94).
<発明が解決しようとする課題>
しかしながら、DL−アラニンを製造した場合
には、D−アラニンのみを取得するために何らか
の光学分割操作が不可避であり、また微生物を用
いてDL−アラニンからL−アラニンのみを資化
させてD−アラニンを得る方法では、原料の約半
分しか有効利用できないことになる。<Problems to be Solved by the Invention> However, when producing DL-alanine, some kind of optical resolution operation is unavoidable in order to obtain only D-alanine, and microorganisms are used to separate L-alanine from DL-alanine. In the method of obtaining D-alanine by assimilating only alanine, only about half of the raw material can be effectively utilized.
そこで本発明者らは、微生物を用いてL−アラ
ニンを選択的にD−アラニンに変換させることに
より、さらに安価で簡便なD−アラニンの製造法
を提供することを課題として鋭意研究した。 Therefore, the present inventors conducted extensive research with the aim of providing a cheaper and simpler method for producing D-alanine by selectively converting L-alanine to D-alanine using microorganisms.
<課題を解決するための手段>
その結果、本発明者らは、ブレビバクテリウム
属に属する微生物が驚くべきことにL−アラニン
を効率よくD−アラニンに変換することを見出
し、本発明を完成した。ところでかかる方法によ
るD−アラニンの生産方法はいかなる微生物を用
いるものもいまだ知られておらず、まつたく新規
な技術である。<Means for Solving the Problems> As a result, the present inventors discovered that a microorganism belonging to the genus Brevibacterium surprisingly efficiently converts L-alanine into D-alanine, and completed the present invention. did. By the way, the method for producing D-alanine using any microorganism has not yet been known, and is a completely new technology.
すなわち本発明は、ブレビバクテリウム属に属
し、L−アラニンをD−アラニンに変換する能力
を有する微生物を用いて、L−アラニンをD−ア
ラニンに変換せしめ、生成蓄積したD−アラニン
を採取することを特徴とするD−アラニンの製造
法に関するものである。なお、L−アラニンは純
度100%のものを用いる必要はなく任意の割合で
D体を含むものも使用できる。 That is, the present invention converts L-alanine to D-alanine using a microorganism that belongs to the genus Brevibacterium and has the ability to convert L-alanine to D-alanine, and collects the D-alanine that has been produced and accumulated. The present invention relates to a method for producing D-alanine, which is characterized by the following. Note that it is not necessary to use L-alanine with a purity of 100%, and one containing the D-isomer in any proportion can also be used.
次に、本発明を詳細に説明する。 Next, the present invention will be explained in detail.
本発明で用いられる微生物は、ブレビバクテリ
ウム属に属し、L−アラニンをD−アラニンに変
換する能力を有する微生物であり、かかる性質を
有していれば、他の要求性、薬剤抵抗性の性質を
もつもので本発明の範囲に含まれる。 The microorganism used in the present invention belongs to the genus Brevibacterium and has the ability to convert L-alanine to D-alanine. It is within the scope of the present invention.
本発明で用いられる株の代表的なものとして
は、たとえば、ブレビバクテリウム・ラクトフア
ーメンタムDCSR17−2(微工研条寄第2024号)
が挙げられる。この株は、ブレビバクテリウム・
ラクトフアーメンタムATCC13869(ビオチン要求
性)より誘導されたもので、D−シクロセリンに
対して耐性を有する変異株であり、適当な条件下
でD−アラニンを発酵生産することができる。 Typical strains used in the present invention include, for example, Brevibacterium lactofamentum DCSR17-2 (Feikoken Jokyo No. 2024)
can be mentioned. This strain is Brevibacterium
Lactofermentum ATCC13869 (biotin-requiring) is a mutant strain that is resistant to D-cycloserine, and can ferment and produce D-alanine under appropriate conditions.
変異株の誘導は、通常の変異処理法によつて比
較的容易にできる。すなわち、D−シクロセリン
に耐性を有する変異株を得るには、親株を紫外線
照射するかあるいは変異誘発剤(たとえば、N−
メチル−N′−ニトロ−N−ニトロシグアニジン、
エチルメタンスルホン酸など)で処理したのち、
親株が十分に生育できないような量のD−シクロ
セリンを含む培地で親株に比べて有意に生育可能
な菌株を取得すればよい。 Mutant strains can be induced relatively easily by conventional mutation treatment methods. That is, to obtain a mutant strain resistant to D-cycloserine, the parent strain must be irradiated with ultraviolet rays or a mutagenic agent (for example, N-
Methyl-N'-nitro-N-nitrocyguanidine,
After treatment with ethyl methanesulfonic acid, etc.),
What is necessary is to obtain a strain that can grow significantly compared to the parent strain in a medium containing an amount of D-cycloserine that does not allow the parent strain to grow sufficiently.
本発明方法で使用する菌を培養する培地として
は、通常微生物の培養に汎用される各種栄養源を
使用できる。たとえば炭素源としてはグルコー
ス、糖蜜、デンプン加水分解液などの糖類、酢酸
などの有機酸、エタノールなどのアルコール類、
安息香酸などの有機化合物、窒素源としては、硫
安、硝安、塩安、リン安、尿素、アンモニア、そ
の他を利用でき、無機アンモニウム塩の種類によ
つてはたとえばリン酸塩、炭酸カルシウムなどの
無機塩を必要とする場合もある。また、上記培地
には微生物の生育をよくするためにたとえば有機
窒素源、ビタミン、微量の金属イオンなどを添加
するのが好ましいが通常安価な味液、コーンスチ
ープリカーなどの添加によつて十分それらの目的
を達成することができる。 As the medium for culturing the bacteria used in the method of the present invention, various nutrient sources commonly used for culturing microorganisms can be used. For example, carbon sources include sugars such as glucose, molasses, and starch hydrolyzate, organic acids such as acetic acid, alcohols such as ethanol,
Organic compounds such as benzoic acid and nitrogen sources include ammonium sulfate, ammonium nitrate, ammonium chloride, ammonium phosphorus, urea, ammonia, and others. Depending on the type of inorganic ammonium salt, inorganic compounds such as phosphate and calcium carbonate can be used. Some may require salt. In addition, it is preferable to add organic nitrogen sources, vitamins, trace amounts of metal ions, etc. to the above medium in order to improve the growth of microorganisms, but usually the addition of inexpensive flavoring liquids, corn steep liquor, etc. is sufficient. can achieve the objectives of
本発明において、上記微生物の培養は、培地を
振盪もしくは通気撹拌するごとき好気的条件下に
実施するのが好ましい。培養温度は通常20〜40
℃、とりわけ30℃付近にあることが好ましい。ま
た、培地のPHは通常5〜9であり、好ましくは、
中性付近に維持することが望ましい。 In the present invention, the cultivation of the microorganism is preferably carried out under aerobic conditions such as shaking or aerating the medium. Culture temperature is usually 20-40
℃, especially preferably around 30℃. In addition, the pH of the medium is usually 5 to 9, preferably
It is desirable to maintain it near neutrality.
かくして数日間培養したのち、その培養液に直
接もしくは分離菌体を含む反応液にL−アラニン
もしくはL−アラニンを任意の割合で含むD,L
−アラニンを添加し、さらに数日間培養すれば培
地中にD−アラニンが生成蓄積する。 After culturing in this way for several days, L-alanine or D,L containing L-alanine in any proportion is added directly to the culture solution or to the reaction solution containing the isolated bacterial cells.
- D-alanine is produced and accumulated in the medium by adding alanine and culturing for several more days.
また、培養培地にあらかじめL−アラニンを添
加して滅菌し、微生物を接種して数日間培養して
も培地中にD−アラニンが生成蓄積する。なお、
L−アラニンを任意の割合で含むD,L−アラニ
ンを用いても同様な結果が得られる。培養終了
後、生成したD−アラニンは、たとえばイオン交
換法、吸着法、沈澱法などの公知の単離精製操作
を組合せて用いることにより容易に採取すること
ができる。 Furthermore, even if the culture medium is sterilized by adding L-alanine in advance, inoculated with microorganisms, and cultured for several days, D-alanine is produced and accumulated in the medium. In addition,
Similar results can be obtained using D,L-alanine containing L-alanine in any proportion. After completion of the culture, the produced D-alanine can be easily collected by using a combination of known isolation and purification operations such as, for example, ion exchange method, adsorption method, and precipitation method.
<実施例>
以下、実施例により本発明を具体的に説明す
る。<Example> Hereinafter, the present invention will be specifically explained with reference to Examples.
実施例1 (菌株の取得)
ブレビバクテリウム・ラクトフアーメンタム
ATCC13869(ビオチン要求性)の菌体に常法によ
りN−メチル−N′−ニトロ−N−ニトロソグア
ニジン処理(300μg/ml、30℃で10分)したの
ち、この細胞をD−シクロセリン50mg/lを添加
した寒天培地(グルコース2%、硫安1%、リン
酸第1カリウム0.1%、硫酸マグネシウム・7水
和物0.04%、塩化ナトリウム0.05%、尿素0.25%、
硫酸第1鉄・7水和物10mg/l、硫酸マンガン・
4水和物10mg/l、ビオチン50μg/lを含む完
全合成培地)に塗布した。次に30℃で5〜7日培
養し、生じた大きなコロニーを釣菌分離して、D
−シクロセリン耐性株(ブレビバクテリウム・ラ
クトフアーメンタムDCSR−26)を取得した。Example 1 (Acquisition of bacterial strain) Brevibacterium lactofamentum
After treating ATCC13869 (biotin auxotrophic) cells with N-methyl-N'-nitro-N-nitrosoguanidine (300 μg/ml, 10 minutes at 30°C) using a conventional method, the cells were treated with D-cycloserine 50 mg/l. Agar medium supplemented with (2% glucose, 1% ammonium sulfate, 0.1% potassium phosphate, 0.04% magnesium sulfate heptahydrate, 0.05% sodium chloride, 0.25% urea,
Ferrous sulfate heptahydrate 10mg/l, manganese sulfate
Completely synthetic medium containing 10 mg/l of tetrahydrate and 50 μg/l of biotin) was coated. Next, culture at 30℃ for 5 to 7 days, isolate the resulting large colonies, and
- A cycloserine-resistant strain (Brevibacterium lactofamentum DCSR-26) was obtained.
得られたブレビバクテリウム・ラクトフアーメ
ンタムDCSR−26をさらに同様の処理を施し、同
様の培地で培養しD−シクロセリン高耐性株(ブ
レビバクテリウム・ラクトフアーメンタム
DCSR17−2)を取得した。 The obtained Brevibacterium lactofamentum DCSR-26 was further subjected to the same treatment and cultured in the same medium to obtain a D-cycloserine highly resistant strain (Brevibacterium lactofamentum).
DCSR17-2) was obtained.
実施例2 (分離菌体法)
グルコース10%、硫安3%、リン酸第1カリウ
ム0.05%、リン酸第2カリウウ0.05%、硫酸マグ
ネシウム・7水和物0.025%、味液2%、炭酸カ
ルシウム3%、ビオチン30μg/lを含む培地
(PH7.25)40mlを1lエルレンマイヤーフラスコに
分注し、120℃、10分間オートクレーブ滅菌した
培養培地に、ブレビバクテリウム・ラクトフアー
メンタムDCSR17−2を1白金耳接種し、30℃で
5日間培養した。培養液より菌体を遠心分離し、
グルコース4%、リン酸第1カリウム0.05%、リ
ン酸第2カリウム0.05%、硫酸マグネシウム・7
水和物0.025%、味酸2%、炭酸カルシウム3%、
ビオチン30μg/l、L−アラニン4%を含む無
アンモニア源反応液(PH7.25)40mlに懸濁し、30
℃で45時間反応した結果、反応液中に38.6g/l
のD−アラニンが蓄積した。一方、L−アラニン
を添加しない反応液を同様に反応させた結果、ア
ラニンの蓄積は0.5g/l以下であつた。Example 2 (Isolated cell method) Glucose 10%, Ammonium sulfate 3%, Potassium phosphate 0.05%, Potassium phosphate 0.05%, Magnesium sulfate heptahydrate 0.025%, Flavor liquid 2%, Calcium carbonate Dispense 40 ml of a medium (PH7.25) containing 3% biotin and 30 μg/l of biotin into a 1 liter Erlenmeyer flask, and add Brevibacterium lactofamentum DCSR17-2 to the culture medium that has been autoclaved at 120°C for 10 minutes. One platinum loop was inoculated and cultured at 30°C for 5 days. Centrifuge the bacterial cells from the culture solution,
Glucose 4%, Potassium phosphate 0.05%, Potassium phosphate 0.05%, Magnesium sulfate 7
Hydrate 0.025%, taste acid 2%, calcium carbonate 3%,
Suspend in 40 ml of ammonia-free source reaction solution (PH7.25) containing 30 μg/l of biotin and 4% L-alanine,
As a result of reacting at ℃ for 45 hours, 38.6 g/l was found in the reaction solution.
of D-alanine was accumulated. On the other hand, when a reaction solution to which L-alanine was not added was similarly reacted, the accumulation of alanine was 0.5 g/l or less.
D体およびL体のアラニンの分析は市販のD−
アミノ酸オキシダーゼを用いる酵素法によりおよ
び住友化学OA−1000光学分割用カラムを用いて
高速液体クロマトグラフイー(HPLC)で測定し
た。 D- and L-form alanine can be analyzed using commercially available D-
It was measured by an enzymatic method using amino acid oxidase and by high performance liquid chromatography (HPLC) using a Sumitomo Chemical OA-1000 optical resolution column.
実施例3 (分離菌体法)
実施例2と同様の方法で培養後分離したブレビ
バクテリウム・ラクトフアーメンタムDCSR17−
2の菌体をグルコース4%、リン酸第1カリウム
0.05%、リン酸第2カリウム0.05%、硫酸マグネ
シウム・7水和物0.025%、味液2%、炭酸カル
シウム3%、ビオチン30μg/l,D,L−アラ
ニン4%を含む無アンモニア源反応液(PH7.25)
40mlに懸濁し、30℃で45時間反応した結果、反応
液中に39.7g/lのD−アラニンが蓄積した。Example 3 (Isolated cell method) Brevibacterium lactofamentum DCSR17- isolated after culturing in the same manner as in Example 2
2 bacterial cells with 4% glucose and potassium phosphate
Ammonia-free reaction solution containing 0.05% dipotassium phosphate, 0.05% magnesium sulfate heptahydrate, 2% taste liquid, 3% calcium carbonate, 30 μg/l biotin, 4% D,L-alanine. (PH7.25)
As a result of suspending the suspension in 40 ml and reacting at 30°C for 45 hours, 39.7 g/l of D-alanine was accumulated in the reaction solution.
一方、D,L−アラニンを添加しない反応液を
同様に反応させた結果、アラニンの蓄積は0.5
g/l以下であつた。 On the other hand, when a reaction solution without D,L-alanine was reacted in the same way, the accumulation of alanine was 0.5
g/l or less.
D体およびL体のアラニン分析は実施例2と同
様に行つた。 D- and L-form alanine analysis was performed in the same manner as in Example 2.
実施例 4
実施例2と同様の培養培地にブレビバクテリウ
ム・ラクトフアーメンタムDCSR17−2を接種
し、30℃で3日間培養しDL−アラニン20g/l
を添加した。さらに64時間培養した結果、第1図
のごとく培地中に48.8g/lのD−アラニンが生
成蓄積した。Example 4 Brevibacterium lactofamentum DCSR17-2 was inoculated into the same culture medium as in Example 2, and cultured at 30°C for 3 days to produce 20 g/l of DL-alanine.
was added. As a result of further culturing for 64 hours, 48.8 g/l of D-alanine was produced and accumulated in the medium as shown in FIG.
この培養液200mlから菌体を遠心分離して除去
し得られる上澄液を脱色炭処理した。この脱色炭
処理液を強力カチオン交換樹脂ダイヤイオンSK
−1B(H+型)を充填したカラムに通搭してD−
アラニンを吸着させ、水洗後2Nアンモニア水で
溶出し、D−アラニンの分画を濃縮し、得られた
濃縮液にエタノールを加え析出する結晶を口取し
た。この結晶をエタノールにより再結晶すること
によりD−アラニンの結晶7.2gを得た。 The bacterial cells were removed from 200 ml of this culture solution by centrifugation, and the resulting supernatant was treated with decolorizing charcoal. This decolorizing charcoal treatment liquid is used as a strong cation exchange resin Diaion SK.
D-
Alanine was adsorbed, washed with water, eluted with 2N ammonia water, the D-alanine fraction was concentrated, ethanol was added to the resulting concentrated solution, and the precipitated crystals were collected. The crystals were recrystallized from ethanol to obtain 7.2 g of D-alanine crystals.
光学純度 99.4%
比旋光度〔α〕25 D=−14.2°(C=6,1N−HCl)
D体およびL体のアラニン分析は実施例2と同
様に行つた。 Optical purity 99.4% Specific rotation [α] 25 D = -14.2° (C = 6, 1N-HCl) Analyzes of D-form and L-form alanine were conducted in the same manner as in Example 2.
一方、D,L−アラニンを添加せずにそのまま
培養した場合、第1図のごとく30.9g/lのD−
アラニンしか生成蓄積せず、D,L−アラニン20
g/lよりD−アラニン17.9g/lが生成蓄積で
きたことになる。 On the other hand, when cultured without adding D,L-alanine, 30.9 g/l of D-
Only alanine is produced and accumulated, D, L-alanine 20
g/l, this means that 17.9 g/l of D-alanine was produced and accumulated.
<発明の効果>
本発明によれば、微生物を用いてL−アラニン
をD−アラニンに交換することが可能になつた。
そのためDL−アラニンの光学分割あるいはL−
アラニンの資化が不要となり、安価かつ簡便に
DL−アラニンを取得することができるようにな
り、その工業的価値は大きい。<Effects of the Invention> According to the present invention, it has become possible to exchange L-alanine with D-alanine using microorganisms.
Therefore, optical resolution of DL-alanine or L-
No need to assimilate alanine, making it cheaper and easier
It has become possible to obtain DL-alanine, and its industrial value is great.
第1図は実施例4において培養時間と培地中の
D−アラニン蓄積量との関係を示す図である。
FIG. 1 is a diagram showing the relationship between culture time and the amount of D-alanine accumulated in the medium in Example 4.
Claims (1)
に属し、L−アラニンをD−アラニンに変換する
能力を有する微生物を用いて、L−アラニンをD
−アラニンに変換せしめ、生成蓄積したD−アラ
ニンを採取することを特徴とするD−アラニンの
製造法。1. Using a microorganism that belongs to the genus Brevibacterium and has the ability to convert L-alanine to D-alanine, L-alanine is converted to D-alanine.
- A method for producing D-alanine, which comprises converting it into alanine and collecting D-alanine that has been produced and accumulated.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13893988A JPH01309691A (en) | 1988-06-06 | 1988-06-06 | Production of d-alanine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13893988A JPH01309691A (en) | 1988-06-06 | 1988-06-06 | Production of d-alanine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01309691A JPH01309691A (en) | 1989-12-14 |
| JPH0563156B2 true JPH0563156B2 (en) | 1993-09-09 |
Family
ID=15233679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13893988A Granted JPH01309691A (en) | 1988-06-06 | 1988-06-06 | Production of d-alanine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH01309691A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4133822B2 (en) * | 2001-10-04 | 2008-08-13 | 株式会社武蔵野化学研究所 | Method for producing D-alanine |
-
1988
- 1988-06-06 JP JP13893988A patent/JPH01309691A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01309691A (en) | 1989-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2633357A1 (en) | Method for producing optically active compound | |
| US4492757A (en) | Process for preparing L-threonine | |
| JPS5922516B2 (en) | Method for producing L-phenylalanine | |
| GB2161159A (en) | Improved transamination process for producing L-amino acids | |
| JPH0563156B2 (en) | ||
| JP3006907B2 (en) | Method for producing L-alanine by fermentation method | |
| EP0310949B1 (en) | Process for producing d-alanine | |
| JP3758680B2 (en) | Method for producing L-2-aminoadipic acid | |
| KR0146493B1 (en) | Process for producing l-alanine by fermentation | |
| JPH04218385A (en) | Production of r(-)-mandelic acid | |
| JP3117790B2 (en) | Method for producing L-α-aminoadipic acid | |
| JP3289349B2 (en) | Method for producing D-alanine by fermentation method | |
| US5478733A (en) | Process for producing L-alanine by fermentation with arthrobacter | |
| US5254464A (en) | Process for producing D-alanine | |
| JPWO1996031616A1 (en) | Method for producing L-2-aminoadipic acid | |
| JPH03236786A (en) | Production of l-threonine by fermentation method | |
| JPH02171194A (en) | Production of d-alanine by fermentation method | |
| JP2833084B2 (en) | Production method of L-proline by fermentation method | |
| JPH05111385A (en) | Method for producing L-alanine | |
| JPWO1993010252A1 (en) | Method for producing L-alanine by fermentation | |
| JPH04248988A (en) | Production of l-proline by fermentation method | |
| JPH06245782A (en) | Production of trans-4-hydroxy-l-proline | |
| JPH0378999B2 (en) | ||
| JPS6291191A (en) | Method for producing L-isoleucine | |
| JPH08154692A (en) | Production of d-2-aminobutyric acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |